<DOC>
	<DOCNO>NCT01317550</DOCNO>
	<brief_summary>The goal clinical research study compare armodafinil minocycline give alone combination learn good control symptom , side effect chemoradiation , give treat lung cancer .</brief_summary>
	<brief_title>A Study Reducing Symptom Burden Produced Chemoradiation Treatment Non Small Cell Lung Cancer Minocycline Armodafinil</brief_title>
	<detailed_description>The Study Drugs : Armodafinil design prevent excessive sleepiness . Minocycline antibiotic . Minocycline show interrupt cytokine production , may help reduce multiple symptom . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect . Study Groups : If agree take part study , randomly assign ( roll dice ) join 1 4 group . - Group 1 take armodafinil placebo . - Group 2 take minocycline placebo . - Group 3 take armodafinil minocycline . - Group 4 take placebo alone . Neither study staff see clinic know receive study drug ( ) and/or placebo ( ) . However , need safety , study staff able find study drug receiving . If need , study , may receive standard care treat doctor . Study Drug Administration : You take study drug ( ) /placebos every day 10 week . You take drug ( ) /placebo ( ) full glass water . If get upset stomach , take food . You give pamphlet information take study drugs/placebos . You bring study drug/placebo capsule clinic every study visit . Completing Symptom Questionnaire : Throughout study , ask complete symptom questionnaire . You ask symptom therapy may experience may interfere daily activity . The study staff either meet regular clinic visit call home time convenient . In clinic , complete questionnaire paper pen , enter answer electronic tablet computer . On phone , study staff ask question record answer paper enter computer . You complete symptom questionnaire begin chemoradiation 1 time week Weeks 1-16 study . The symptom questionnaire take 5 minute complete . Study Visits : Before begin chemoradiation : - You complete 4 questionnaire pain symptom , mood , quality life . Completing 4 questionnaire take 15 minute . - If able become pregnant , urine pregnancy test . The study staff give pregnancy test kit schedule visit , review record result test pick study drug pharmacy . The pregnancy test repeat week 1 , 4 , 7 , 12 ( first follow-up clinic visit post-treatment ) 30 day study drug stop . During last week chemoradiation ( Week 7 ) : -You complete 3 questionnaire symptom , mood , quality life . These questionnaire take 10 minute total complete . After Week 7 , study staff call 1 time week check Week 10 . This phone call last minute . If several side effect chemoradiation , phone call may take long . About Week 12 ( first routine follow-up clinic visit post-treatment ) : - You complete 3 questionnaire symptom , mood , quality life . - If smoke begin study , complete questionnaire asks stop smoke time study . This take minute complete . - You ask complete another questionnaire ask satisfaction study drug ( ) . This take minute . Length Study : You study 16 week . You take study drug ( ) 10 week complete symptom survey Week 16 . You take study early intolerable side effect . This investigational study . Armodafinil FDA approve commercially available treatment excessive sleepiness . Minocycline FDA approve commercially available treatment bacterial infection . The use drug help reduce chemoradiation symptom investigational . Up 12 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>1 . Patients pathologically proven diagnosis NSCLC consent concurrent chemoradiation therapy MD Anderson . 2 . Patients &gt; =18 year old 3 . Patients receive chemoradiation platinum/taxanebased chemotherapy total radiation dose &gt; 50 Gy , per treat physician 's assessment 4 . Patients speak English Spanish ( due novel research complexity , accrue English Spanishspeaking patient protocol ) 5 . Patients must willing able review , understand , provide write consent start therapy 1 . Patients take medication condition potentially preclude use study medication intervention , determine treat physician 2 . Patients enrol symptom management treatment clinical trial 3 . Patients currently take methylphenidate and/or dextroamphetamine . 4 . Patients history clinically significant cutaneous drug reaction , history clinically significant hypersensitivity reaction , include multiple allergy drug reaction document patient medical record 5 . Patients preexist psychosis bipolar disorder . 6 . Patients preexist renal impairment : The screening cut serum creatinine &gt; 1.5 time upper limit normal ( ULN ) , accord MD Anderson test standard , do oncologist qualify CXRT . 7 . Patients preexist hepatic impairment : The screening total bilirubin &gt; 1.5 time ULN do oncologist qualify CXRT . The screen &gt; 2 time upper limit normal hepatotoxicity , alkaline phosphatase ( ALP ) alanine aminotransferase ( ALT ) ( aspartate aminotransferase [ AST ] order available medical record ) do oncologist qualify CXRT . 8 . Patients preexist Tourette 's syndrome . 9 . Patients hypersensitivity tetracycline . 10 . Patients pregnant . Pregnancy confirm negative urine test . Study staff provide pregnancy kit woman make sure result know recorded followup note Clinic Station additional study drug prescription fill Pharmacy 11 . Patients uncontrolled cardiac disease , within past six month history leave ventricular hypertrophy , myocardial infarction , history mitral valve prolapse syndrome previous central nervous system ( CNS ) stimulant use . 12 . Patients take medicine strong CYP3A4 inhibitor inducer ( include conivaptan , indinavir , nelfinavir , ritonavir , nefazodone , phenytoin ) , strong CYP2C19 inhibitor ( include citalopram clopidogrel ) . 13 . Patients vitamin K antagonist warfarin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Concurrent Chemoradiation</keyword>
	<keyword>CXRT</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Pain</keyword>
	<keyword>Disturbed Sleep</keyword>
	<keyword>Lack Appetite</keyword>
	<keyword>Drowsiness</keyword>
	<keyword>Armodafinil</keyword>
	<keyword>Nuvigil</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Dynacin</keyword>
	<keyword>Minocin</keyword>
	<keyword>Minocin PAC</keyword>
	<keyword>Myrac</keyword>
	<keyword>Solodyn</keyword>
	<keyword>Placebo</keyword>
</DOC>